Nephrotoxicity of Monosodium Glutamate (MSG) in Wistar Rats

Main Article Content

Augustine I. Airaodion
Kenneth O. Ngwogu
Ada C. Ngwogu
Anthony U. Megwas
John A. Ekenjoku

Abstract

Background: Nowadays, monosodium glutamate (MSG) is frequently used as a flavour enhancer, the fact of which makes it one of the most applied food additives in modern nutrition all over the world. But accurate information on the daily intake of specific food additives by individuals is difficult to obtain especially for food additives that are considered to be safe.

Aim: This study sought to investigate the nephrotoxic effect of MSG on Wistar rats.

Methods: Forty Wistar rats were used for this study. Fifteen of the rats were used for acute toxicity test (LD50) and twenty-five for the experiment. Twenty-five (25) Wistar rats were divided into five groups of 5 rats each. Animals in groups A, B, C, and D were respectively administered 500 mg/kg, 750 mg/kg, 1000 mg/kg and 1,250 mg/kg b. w. of MSG thoroughly mixed with standard feed for eight weeks. Animals in group E received an equal amount of feeds without MSG added. This group served as the control group. At the end of 8 weeks, animals were fasted overnight and sacrificed under diethyl ether anaesthesia. Renal indices were determined using standard methods.

Results: The LD50 was taken to be 500 mg/kg b. w., which is the median of 200 mg/kg b. w. which did not kill any of the animals and 800 mg/kg b. w. that killed all its animals. MSG was observed to increase the concentrations of creatinine, urea, total bilirubin, conjugated bilirubin and unconjugated bilirubin.

Conclusion: The elevation of renal indices by MSG is an indication that it is nephrotoxic.

Keywords:
Monosodium glutamate, lethal dose, nephrotoxicity, wistar rats

Article Details

How to Cite
Airaodion, A. I., Ngwogu, K. O., Ngwogu, A. C., Megwas, A. U., & Ekenjoku, J. A. (2020). Nephrotoxicity of Monosodium Glutamate (MSG) in Wistar Rats. International Journal of Advances in Nephrology Research, 3(1), 1-10. Retrieved from http://journalijanr.com/index.php/IJANR/article/view/30097
Section
Original Research Article

References

Perazella M. Renal vulnerability to drug toxicity. Clin. J. Am. Soc. Nephrol. 2009;4:1275–1283.

Zhou Y, Vaidya VS, Brown RP, Zhang J, Rosenzweig BA, Thompson KL, Miller TJ, Bonventre JV, Goering PL. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol. Sci. 2008;101:159–170.

Guyton A, Hall J. Textbook of Medical Physiology, W.B. Saunders Co., Philadelphia; 1996.

Airaodion AI, Ogbuagu EO, Osemwowa EU, Ogbuagu U, Esonu CE, Agunbiade AP, Okereke D, Oloruntoba AP. Toxicological effect of monosodium glutamate in seasonings on human health. Global Journal of Nutrition & Food Science. 2019;1(5):1-9.

David TW. MSG – Flavor enhancer or Deadly Killer. AU J.T. 2008;12(1):43- 49.

Chaudhari N, Landin AM, Roper SA. Metabotropic glutamate receptor variant functions as a taste receptor. Nature Neuroscience. 2000;3(2):113-119.

Kurihara K. Umami the fifth basic taste: History of studies on receptor mechanisms and role as a food flavor. BioMed Research International. 2015;189(402):1-10.

Meraiyebu A, Akintayo CO, Uzoechi AC, Okere S. The effects of orally administered monosodium glutamate (MSG) on blood thrombocyte, blood coagulation and bleeding in rats. IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS). 2012;4(1):04-08.

Obochi GO, Malu SP, Obi-Abang M, Alozie Y, Iyam MA. Effect of garlic extracts on monosodium glutamate (MSG) induced fibroid in Wistar rats. Pakistan Journal of Nutrition. 2009;8(7):970-976.

Egbuonu ACC, Obidoa O, Ezeokonkwo CA, Ezeanyika LUS, Ejikeme PM. Hepatotoxic effects of low dose oral administration of monosodium glutamate in male albino rats. African Journal of Biotechnology. 2009;8(13):3031-3035.

Onyema OO, Farombi EO, Emerole GO, Ukoha AI, Onyeze GO. Effect of vitamin E on monosodium glutamate induced hepatotoxicity and oxidative stress in rats. Indian Journal of Biochemistry & Biophysics. 2005;43:20-24.

Meraiyebu A, Akintayo CO, Uzoechi AC, Okere S. The effects of orally administered monosodium glutamate (MSG) on blood thrombocyte, blood coagulation and bleeding in rats. IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS). 2012;4(1):04-08.

Onyema OO, Alisi CS, Ihetuge AP. Monosodium glutamate induces oxidative stress and affects glucose metabolism in the kidney of rats. International Journal of Biochemistry Research & Review. 2012;2(1):1-11.

Nwajei JC, Onuoha SC, Essien EB. Effects of Oral administration of selected food seasonings consumed in Nigeria on some sex hormones of Wistar Albino Rats. IOSR Journal of Biotechnology and Biochemistry (IOSR-JBB). 2015;1(5):15-21.

Kolawole OT. Assessment of the effects of monosodium glutamate on some biochemical and hematological parameters in adult Wistar rats. American Journal of BioScience. 2013;1(1):11-15.

Lorke D. A new approach to practical acute toxicity testing. Arch. Toxicol. 1983;53:275-289.

Toora BD, Rejagopal G. Measurement of creatinine concentration by Jaffe’s Reaction. Indian Journal of Experimental Biology. 2002;40(3):352–354.

Fesus PD, Pressac M, Braconnier F, Aymard P. Automated determination of urinary Na, K, inorganic phosphate, urea, and creatunine without sample dilution, with the RA-XT. Cliii Chem. 1983;35:481-483.

Royden NR, Alfred P. A new Diazo method for the determination of bilirubin. Clinical Chemistry. 1962;8(6): 570-578.

Compernolle F. Bilirubin conjugates: Isolation, structure analysis and synthesis. Bilirubin, Vol 1: Chemistry. Boca Raton, FL:CRC Press. 1982;2:59-74.

Airaodion AI, Ogbuagu EO, Ewa O, Ogbuagu U, Awosanya OO, Adekale OA. Ameliorative efficacy of methanolic extract of Corchorus olitorius leaves against acute ethanol-induced oxidative stress in Wistar Rats. Asian Journal of Biochemistry, Genetics and Molecular Biology. 2019;7(6):1-9.

Shittu OK, Lawal B, Alozieuwa BU, Haruna GM, Abubakar AN, Berinyuy EB. Alteration in biochemical indices following chronic administration of methanolic extract of Nigeria bee Propolis in Wistar rats. Asian Pac J Trop Dis. 2015; 5(8):654-657.

Yohei D, Yoshio I, Fumiki Y, Kei K, Shin-Ichirou H, Yoshinori K, Satoko N, Takeshi H, Yuhei K. Renal resistive index and cardiovascular and renal outcomes in essential hypertension. Hypertension. 2012;60:770-777.

Mandell EE, Jones F, Willis MJ, Cargill WH. Renal excretion of creatinine and inulin in man. J Lab Clin Med. 2003;42:621-637.

Kassirer JP. Clinical evaluation of kidney function-glomerular function. N Engl J Med. 2001;285:385-9.

Miller BF, Leaf A, Mamby AR, Miller Z. Validity of the endogenous creatinine clearance as a measure of glomerular filtration rate in the diseased human kidney. Journal of Clinical Investigations. 2002;31:309-313.

Abass MA, El-Haleem MRA. Evaluation of monosodium glutamate induced neurotoxicity and nephrotoxicity in adult male Albino rats. Journal of American Science. 2011;7(8):264-476.

Shapiro SM. Bilirubin toxicity in the developing nervous system. Pediatr Neurol. 2003;29:410-421.

Schwertner HA, Vítek L. Bilirubin and atherosclerotic diseases. Atherosclerosis. 2008;198:1–11.

Perlstein TS, Pande RL, Creager MA, Weuve J, Beckman JA. Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004. American Journal of Medicine. 2008;121: 781–788.

Senafi SB, Clarke DJ, Burchell B. Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochemical Journal. 1994;303:233–240.

Fevery J, Blanckaert N, Heirwegh KPM, Preaux AM, Berthelot P. Quantitative assessment of the multiple processes responsible for bilirubin homeostasis in health and disease. Journal of Clinical Investigation. 1997;60:970-979.

Siow RC, Sato H, Mann GE. Heme oxygenase carbon monoxide signalling pathway in atherosclerosis: Anti -atherogenic actions of bilirubin and carbonmonoxide? Cardiovascular Research. 1999;41(2):385 94.

Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clinical Chemistry. 1994; 40(1):18 23.